Literature DB >> 26400524

MiR-21 and miR-183 can simultaneously target SOCS6 and modulate growth and invasion of hepatocellular carcinoma (HCC) cells.

Z-B Li1, Z-Z Li, L Li, H-T Chu, M Jia.   

Abstract

OBJECTIVE: Both miR-21 and miR-183 are upregulated in hepatocellular carcinoma (HCC) and are considered as oncomiR. However, their oncogenic roles are still not fully understood. This study aimed to explore the regulative role of miR-21 and miR-183 over suppressors of cytokine signaling 6 (SOCS6), a negative regulator of cytokine receptor signaling.
MATERIALS AND METHODS: qRT-PCR analysis was performed to assess miR-21 and miR-183 expression in tumor tissues obtained from HCC patients and in HCC cell lines HepG2 and Hep3B. Their regulation over SOCS6 is verified using dual luciferase assay and Western blot analysis. The function of miR-21/miR-183-SOCS6 axis in cell growth, invasion and apoptosis was studied.
RESULTS: MiR-21 and miR-183 expression in HCC tissues than in adjacent normal tissues. Knockdown of miR-21 and miR-183 in HepG2 and Hep3B cells could decrease cell viability, increase cell apoptosis and decrease cell invasion. Based on the dual luciferase assay and Western blot analysis, we confirmed that both miR-21 and miR-183 can simultaneously target SOCS6 and modulate its expression at protein level. Overexpression of SOCS6 without 3'UTR could significantly lower cell growth rate and invasion capability, but increase relative caspase 3/7 activity and the ratio of apoptotic cells. However, these effects could not be blocked by miR-21 or miR-183 mimics.
CONCLUSIONS: This study revealed a novel miR-21/miR-183-SOCS6 axis that might play an important role in modulating cell growth and invasion of HCC cells.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26400524

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  16 in total

1.  miR-24-3p stimulates migration, invasion and proliferation of prostate cancer cells by targeting suppressor of cytokine signaling 6.

Authors:  Yang Lin; Huifang Cao; Yuxin Tian; Xinping Yang; Changdong Zhou; Qifu Zhang
Journal:  Int J Clin Exp Pathol       Date:  2018-03-01

2.  Evaluating normalization approaches for the better identification of aberrant microRNAs associated with hepatocellular carcinoma.

Authors:  Jing Shen; Qiao Wang; Irina Gurvich; Helen Remotti; Regina M Santella
Journal:  Hepatoma Res       Date:  2016-11-18

3.  MIP From Legionella pneumophila Influences the Phagocytosis and Chemotaxis of RAW264.7 Macrophages by Regulating the lncRNA GAS5/miR-21/SOCS6 Axis.

Authors:  Youfeng Shen; Jian Xu; Shenshen Zhi; Wenyan Wu; Yingying Chen; Qiang Zhang; Yan Zhou; Ze Deng; Wei Li
Journal:  Front Cell Infect Microbiol       Date:  2022-04-29       Impact factor: 6.073

4.  MicroRNA-183 accelerates the proliferation of hepatocyte during liver regeneration through targeting programmed cell death protein 6.

Authors:  Fangxing Hou; Xing Li; Yanfeng Wang; Xiangzuo Xiao
Journal:  Genes Genomics       Date:  2022-02-21       Impact factor: 2.164

5.  The Angiogenic Effect of microRNA-21 Targeting TIMP3 through the Regulation of MMP2 and MMP9.

Authors:  Jianzhong Hu; Shuangfei Ni; Yong Cao; Tao Zhang; Tianding Wu; Xianzhen Yin; Ye Lang; Hongbin Lu
Journal:  PLoS One       Date:  2016-02-12       Impact factor: 3.240

Review 6.  Dysregulation and functional roles of miR-183-96-182 cluster in cancer cell proliferation, invasion and metastasis.

Authors:  Yi Ma; A-Juan Liang; Yu-Ping Fan; Yi-Ran Huang; Xiao-Ming Zhao; Yun Sun; Xiang-Feng Chen
Journal:  Oncotarget       Date:  2016-07-05

Review 7.  MicroRNA-Mediated Regulation of HMGB1 in Human Hepatocellular Carcinoma.

Authors:  Jianing Yan; Shibo Ying; Xiujun Cai
Journal:  Biomed Res Int       Date:  2018-01-31       Impact factor: 3.411

8.  MiR-21 and MiR-155 promote non-small cell lung cancer progression by downregulating SOCS1, SOCS6, and PTEN.

Authors:  Xinying Xue; Yuxia Liu; Yong Wang; Mingming Meng; Kaifei Wang; Xuefeng Zang; Sheng Zhao; Xiaohua Sun; Lei Cui; Lei Pan; Sanhong Liu
Journal:  Oncotarget       Date:  2016-12-20

9.  Screening therapeutic targets of ribavirin in hepatocellular carcinoma.

Authors:  Chen Xu; Liyun Luo; Yongjun Yu; Zhao Zhang; Yi Zhang; Haimei Li; Yue Cheng; Hai Qin; Xipeng Zhang; Hongmei Ma; Yuwei Li
Journal:  Oncol Lett       Date:  2018-04-20       Impact factor: 2.967

10.  The ubiquitin-proteasome system regulates focal adhesions at the leading edge of migrating cells.

Authors:  Anjali Teckchandani; Jonathan A Cooper
Journal:  Elife       Date:  2016-09-22       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.